These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

471 related articles for article (PubMed ID: 28111010)

  • 1. Blocking lysophosphatidic acid receptor 1 signaling inhibits diabetic nephropathy in db/db mice.
    Li HY; Oh YS; Choi JW; Jung JY; Jun HS
    Kidney Int; 2017 Jun; 91(6):1362-1373. PubMed ID: 28111010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lysophosphatidic acid receptor 1 inhibitor, AM095, attenuates diabetic nephropathy in mice by downregulation of TLR4/NF-κB signaling and NADPH oxidase.
    Lee JH; Sarker MK; Choi H; Shin D; Kim D; Jun HS
    Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1332-1340. PubMed ID: 30763641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lysophosphatidic acid increases mesangial cell proliferation in models of diabetic nephropathy via Rac1/MAPK/KLF5 signaling.
    Kim D; Li HY; Lee JH; Oh YS; Jun HS
    Exp Mol Med; 2019 Feb; 51(2):1-10. PubMed ID: 30770784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of ChREBP ubiquitination via the ROS/Akt-dependent downregulation of Smurf2 contributes to lysophosphatidic acid-induced fibrosis in renal mesangial cells.
    Kim D; Nam GY; Seo E; Jun HS
    J Biomed Sci; 2022 May; 29(1):31. PubMed ID: 35538534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autotaxin-LPA axis regulates hMSC migration by adherent junction disruption and cytoskeletal rearrangement via LPAR1/3-dependent PKC/GSK3β/β-catenin and PKC/Rho GTPase pathways.
    Ryu JM; Han HJ
    Stem Cells; 2015 Mar; 33(3):819-32. PubMed ID: 25376707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of lysophosphatidic acid receptor ameliorates Sjögren's syndrome in NOD mice.
    Park E; Kim D; Lee SM; Jun HS
    Oncotarget; 2017 Apr; 8(16):27240-27251. PubMed ID: 28460477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pro-fibrotic activity of lysophosphatidic acid in adipose tissue: in vivo and in vitro evidence.
    Rancoule C; Viaud M; Gres S; Viguerie N; Decaunes P; Bouloumié A; Langin D; Bascands JL; Valet P; Saulnier-Blache JS
    Biochim Biophys Acta; 2014 Jan; 1841(1):88-96. PubMed ID: 24120919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lysophosphatidic acid activates TGFBIp expression in human corneal fibroblasts through a TGF-β1-dependent pathway.
    Jeon ES; Kim JH; Ryu H; Kim EK
    Cell Signal; 2012 Jun; 24(6):1241-50. PubMed ID: 22374302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lysophosphatidylethanolamine utilizes LPA(1) and CD97 in MDA-MB-231 breast cancer cells.
    Park SJ; Lee KP; Kang S; Chung HY; Bae YS; Okajima F; Im DS
    Cell Signal; 2013 Nov; 25(11):2147-54. PubMed ID: 23838008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of
    Wen J; Lin X; Gao W; Qu B; Zuo Y; Liu R; Yu M
    J Ocul Pharmacol Ther; 2019; 35(6):331-340. PubMed ID: 31343394
    [No Abstract]   [Full Text] [Related]  

  • 11. LPA1 receptor activation promotes renal interstitial fibrosis.
    Pradère JP; Klein J; Grès S; Guigné C; Neau E; Valet P; Calise D; Chun J; Bascands JL; Saulnier-Blache JS; Schanstra JP
    J Am Soc Nephrol; 2007 Dec; 18(12):3110-8. PubMed ID: 18003779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased glomerular and tubular expression of transforming growth factor-beta1, its type II receptor, and activation of the Smad signaling pathway in the db/db mouse.
    Hong SW; Isono M; Chen S; Iglesias-De La Cruz MC; Han DC; Ziyadeh FN
    Am J Pathol; 2001 May; 158(5):1653-63. PubMed ID: 11337363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lysophosphatidic Acid Promotes Epithelial-Mesenchymal Transition in Kidney Epithelial Cells via the LPAR1/MAPK-AKT/KLF5 Signaling Pathway in Diabetic Nephropathy.
    Lee GH; Cheon J; Kim D; Jun HS
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer-derived lysophosphatidic acid stimulates differentiation of human mesenchymal stem cells to myofibroblast-like cells.
    Jeon ES; Moon HJ; Lee MJ; Song HY; Kim YM; Cho M; Suh DS; Yoon MS; Chang CL; Jung JS; Kim JH
    Stem Cells; 2008 Mar; 26(3):789-97. PubMed ID: 18065393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lysophosphatidic acid receptor 1 antagonist ki16425 blunts abdominal and systemic inflammation in a mouse model of peritoneal sepsis.
    Zhao J; Wei J; Weathington N; Jacko AM; Huang H; Tsung A; Zhao Y
    Transl Res; 2015 Jul; 166(1):80-8. PubMed ID: 25701366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lysophosphatidic Acid Induces Ligamentum Flavum Hypertrophy Through the LPAR1/Akt Pathway.
    Zhou T; Du L; Chen C; Han C; Li X; Qin A; Zhao C; Zhang K; Zhao J
    Cell Physiol Biochem; 2018; 45(4):1472-1486. PubMed ID: 29466791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chrysin Inhibits Advanced Glycation End Products-Induced Kidney Fibrosis in Renal Mesangial Cells and Diabetic Kidneys.
    Lee EJ; Kang MK; Kim DY; Kim YH; Oh H; Kang YH
    Nutrients; 2018 Jul; 10(7):. PubMed ID: 29987200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lysophosphatidic acid induces erythropoiesis through activating lysophosphatidic acid receptor 3.
    Chiang CL; Chen SS; Lee SJ; Tsao KC; Chu PL; Wen CH; Hwang SM; Yao CL; Lee H
    Stem Cells; 2011 Nov; 29(11):1763-73. PubMed ID: 21915944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lysophosphatidic Acid Receptor 1- and 3-Mediated Hyperalgesia and Hypoalgesia in Diabetic Neuropathic Pain Models in Mice.
    Ueda H; Neyama H; Matsushita Y
    Cells; 2020 Aug; 9(8):. PubMed ID: 32824296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Astragaloside effect on TGF-β1, SMAD2/3, and α-SMA expression in the kidney tissues of diabetic KKAy mice.
    Wang Y; Lin C; Ren Q; Liu Y; Yang X
    Int J Clin Exp Pathol; 2015; 8(6):6828-34. PubMed ID: 26261569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.